Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. The Regulatory Mechanism Of M6a Modification In Gastric Cancer.
  1. Home
  3. The Regulatory Mechanism Of M6a Modification In Gastric Cancer.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
MicroRNAs01:22

MicroRNAs

21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

888
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
888
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K

Related Experiment Video

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

667

The regulatory mechanism of m6A modification in gastric cancer.

Si Wu1, Chunming Li2, Hanghao Zhou1

  • 1Department of Pathology, The First Affiliated Hospital of Zunyi Medical University, No. 149 Dalian Street, Huichuan District, Zunyi, 563000, Guizhou, China.

Discover Oncology
|July 15, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

N6-Methyladenosine (m6A) modification significantly impacts gastric cancer (GC) development by influencing proliferation, apoptosis, and metastasis. m6A-related ncRNAs show promise as future biomarkers for GC diagnosis.

More Related Videos

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

10.9K
Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.4K

Related Experiment Videos

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

667
A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

10.9K
Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • N6-Methyladenosine (m6A) is the most prevalent RNA modification, regulating gene expression at the post-transcriptional level.
  • Gastric cancer (GC) is a major global health concern, necessitating a deeper understanding of its tumorigenesis mechanisms.
  • m6A modification plays a crucial role in various biological processes, including cancer development.

Purpose of the Study:

  • To review and summarize the multifaceted roles of m6A modification in gastric cancer.
  • To elucidate the specific mechanisms by which m6A influences GC progression.
  • To identify potential future applications of m6A-related molecules as diagnostic biomarkers for GC.

Main Methods:

  • Literature review of studies investigating m6A modification in gastric cancer.
  • Analysis of m6A's impact on key cellular processes like proliferation, apoptosis, migration, and invasion.
  • Examination of m6A's association with epithelial-mesenchymal transition (EMT), drug resistance, and aerobic glycolysis in GC.

Main Results:

  • m6A modification significantly influences the proliferation, apoptosis, migration, and invasion of gastric cancer cells.
  • m6A is implicated in crucial aspects of GC progression, including EMT, drug resistance, and altered cellular metabolism (aerobic glycolysis).
  • m6A-related non-coding RNAs (ncRNAs) are emerging as potential biomarkers for predicting GC diagnosis.

Conclusions:

  • m6A modification is a critical regulator in the molecular mechanisms underlying gastric cancer.
  • Understanding m6A's role provides insights into GC tumorigenesis and progression.
  • m6A-related ncRNAs represent a promising avenue for developing novel diagnostic biomarkers for gastric cancer.